Abstract. We have previously documented synthesis of lysophosphatidic acid (LPA) in the bovine endometrium and the increased presence of LPA receptor mRNA expression during pregnancy. Therefore, LPA could contribute to early pregnancy establishment in the cow. In the present study, we investigated the effect of intravaginally administered LPA on pregnancy rates and on the plasma levels of progesterone (P4) and prostaglandins (PGs) in heifers. Animals were inseminated and from day 15 to 18 after estrus were treated intravaginally with saline, LPA (1 mg) or LPA receptor blocker (VPC32183; 1 mg). Blood samples were collected on days 0, 6, 12, 15, 16, 17, 18 and 21 after insemination. Pregnancy was confirmed by ultrasonography and per rectum examination on days 30 and 49-50 after insemination. Intravaginal LPA administration increased the plasma P4 and PGE2 concentrations compared with saline and VPC32183-treated heifers. In the saline and LPA-treated groups, 6 out of 8 heifers were pregnant (75%), whereas the pregnancy rate in the VPC32183-treated heifers was only 37%. We also examined the effects of LPA on PG secretion and PG synthase mRNA expression in stromal and epithelial cells of the bovine endometrium on days 16-18 of pregnancy and the estrous cycle. LPA increased PGE2 production and PGE2 synthase (PGES) mRNA expression in stromal cells during the estrous cycle and pregnancy. On Days 16-18 of pregnancy, LPA inhibited PGF2α production and PGFS mRNA expression in epithelial cells. The results suggest that LPA serves as a luteotropic factor during the estrous cycle and pregnancy, stimulating P4 secretion in vivo and PGE2 secretion in vitro through activation of PGES mRNA expression in stromal cells. Moreover, during the early pregnancy, LPA decreases PGF2α synthesis and mRNA expression for PGFS in epithelial cells of the bovine endometrium. Key words: Cow, Lysophosphatidic acid, Pregnancy, Progesterone, Prostaglandins (J. Reprod. Dev. 56: [411][412][413][414][415][416][417][418][419][420] 2010) he role of lysophosphatidic acid (LPA) in the reproductive system has been studied extensively in mice [1] , pigs [2, 3] , ewes [4] and cows [5] [6] [7] . We found that in the bovine endometrium, in contrast to the mouse, pig and sheep [1] [2] [3] [4] , there is mRNA expression only for the LPA receptor type 1 (LPAR1) [5] . We also demonstrated that LPA is locally produced and released from the bovine endometrium [5] . The LPA concentration and expression of mRNA for LPAR1 in the bovine endometrium are significantly higher during early pregnancy than during the estrous cycle. Moreover, LPA administered into the aorta abdominalis stimulated progesterone (P4) and prostaglandin (PG) E2 secretion during the luteal phase of the estrous cycle in vivo. This LPA-mediated stimulation of PGE2 synthesis might serve as an additional luteotropic factor during the luteal phase of the estrous cycle and on days 8-10 of early pregnancy. However, during early pregnancy, on days 8-10 after conception in the cow, LPA may play an even more important role by stimulating PGE2 synthesis and additionally inhibiting PGF2α synthesis [6] . These data suggest that LPA may play autocrine or paracine roles in the bovine uterus. It has previously been documented in rodents that LPA is involved in oocyte maturation [8] , tubal transport of the ovum [9] and pre-implantation development of embryos [10] . In mice, the LPA signaling pathway has been demonstrated to exert a direct influence on embryo implantation [1] . Therefore, we suggest that LPA could also serve as an important factor contributing to pregnancy establishment at the time of highest interferon tau (IFNτ) production in the cow.
(J. Reprod. Dev. 56: [411] [412] [413] [414] [415] [416] [417] [418] [419] [420] 2010) he role of lysophosphatidic acid (LPA) in the reproductive system has been studied extensively in mice [1] , pigs [2, 3] , ewes [4] and cows [5] [6] [7] . We found that in the bovine endometrium, in contrast to the mouse, pig and sheep [1] [2] [3] [4] , there is mRNA expression only for the LPA receptor type 1 (LPAR1) [5] . We also demonstrated that LPA is locally produced and released from the bovine endometrium [5] . The LPA concentration and expression of mRNA for LPAR1 in the bovine endometrium are significantly higher during early pregnancy than during the estrous cycle. Moreover, LPA administered into the aorta abdominalis stimulated progesterone (P4) and prostaglandin (PG) E2 secretion during the luteal phase of the estrous cycle in vivo. This LPA-mediated stimulation of PGE2 synthesis might serve as an additional luteotropic factor during the luteal phase of the estrous cycle and on days 8-10 of early pregnancy. However, during early pregnancy, on days 8-10 after conception in the cow, LPA may play an even more important role by stimulating PGE2 synthesis and additionally inhibiting PGF2α synthesis [6] . These data suggest that LPA may play autocrine or paracine roles in the bovine uterus. It has previously been documented in rodents that LPA is involved in oocyte maturation [8] , tubal transport of the ovum [9] and pre-implantation development of embryos [10] . In mice, the LPA signaling pathway has been demonstrated to exert a direct influence on embryo implantation [1] . Therefore, we suggest that LPA could also serve as an important factor contributing to pregnancy establishment at the time of highest interferon tau (IFNτ) production in the cow.
In ruminants, like in many other mammals, establishment of pregnancy consists of a sequence of events including maternal recognition of pregnancy and successful implantation. In the cow, there are reports that the conceptus can announce its presence as early as around days 8-9 by changing the immunological response of the mother [11] [12] [13] [14] . However, the most extensively examined events connected with maternal recognition of pregnancy are associated with IFNτ production by the conceptus. In ruminants, the action of IFNτ is mainly based on modulation of PG secretion through suppression of estrogen receptor (ER) expression, and without the actions of estradiol, oxytocin (OT) receptors are not expressed and pulsatile release of luteolytic PGF2α is blocked [15, 16] . However, IFNτ may also cause increased expression of PGendoperoxide synthase-2 (PTGS-2), which leads to a change of the PG production profile from PGF2α towards PGE2 [17, 18] . The conceptus synthesizes and secretes IFNτ between days 10 and 21 to 25, with the maximal production on days 14 to 16 [19, 20] . However, IFNτ production is terminated at the time of the second crucial event in the establishment of pregnancy-implantation (between days 18 and 22).
Bearing in mind the higher LPA concentration and mRNA expression for LPAR1 in the bovine endometrium during early pregnancy, as compared with the estrous cycle, the aim of this study was to test the hypothesis that LPA might contribute to the later period of early pregnancy establishment in the cow (days [15] [16] [17] [18] . To study the potential influence of LPA on early pregnancy establishment in the cow (around the time of the highest IFNτ production by the conceptus, just before implantation) in vivo and in vitro studies were carried out on days 15-18 of pregnancy. [21] . The onset of estrus was determined by the indicative signs (i.e, vaginal mucus, standing behavior) and was confirmed by a veterinarian by ultrasonographic (USG) examination using a DRAMINSKI ANIMAL Profi Scanner (Draminski Electronics in Agriculture, Olsztyn, Poland) and by per rectum examination. Only the animals with behavioral signs of estrus were chosen for the study after positive USG and per rectum examination (n=45 for heifers and n=13 for cows). Estrus was taken as Day 0 of the estrous cycle.
Materials and Methods

Animals
Experimental procedure
Experiment 1: The effect of LPA and LPAR1 blocker (VPC32183) on the pregnancy rate and secretion of P4 and PGs during early pregnancy Preliminary study: Twenty-one heifers were used to choose the effective dose of an LPA agonist and LPAR1 blocker. For infusion of either saline, different doses of LPA agonist (1 oleoyl-sn-glycero-3-lysophosphatidic acid sodium salt, Enzo Life Sciences, Plymouth Meeting, PA 19462-1202; USA, #Alx 300-139-M005; LPA) or the LPAR1 blocker ((S)-phosphoric acid mono-{2-octadec-9-enoylamino-3-[4-(pyridin-2-ylmethoxy)-phenyl]-propyl} ester (ammonium salt), Avanti Polar Lipids, Alabaster, AL 35007-9105, USA; #857340; VPC32183) a catheter was inserted deeply into the vagina, near the cervix of the uterus. All infusions were performed on Day 15 of the estrous cycle. The cows were infused into the vagina with Saline (5 ml; n=3; control group), three different doses of LPA (0.5, 1 and 10 mg in 5 ml of saline; n=3 for each dose) or three different doses of VPC32183 (0.5, 1 and 10 mg in 5 ml of saline; n=3 for each dose) followed by 1 mg of LPA infusion after 0.5 hours. The doses of LPA and VPC32183 were calculated on the basis of previous experiments in vivo and the LPA concentrations in the uterine tissue and in the uterine vein [5] . A polyvinyl catheter was inserted into the jugular vein for frequent collection of blood samples [22] . Bovine uteri were obtained at a local slaughterhouse (Zaklady Miesne "Warmia" in Biskupiec Poland) within 20 min of exsanguination and were transported on ice to the laboratory within 40 min. Before slaughter, the cows with behavioral signs of estrus (n= 13) were divided into two groups, i.e, artificially inseminated (AI) and cyclic animals. The animals chosen for the AI group underwent AI with semen from the same bull. The animals were slaughtered on day 16-18 of the estrous cycle (n=6) or day 16-18 of expected pregnancy (n=7). Estimation of the stages of the estrous cycle was additionally confirmed by macroscopic observation of the ovaries and uterus [23] . Pregnancy was confirmed by flushing the uterus for collection of a viable embryo as described previously [24] . Moreover, the flushed uterine fluid was collected, and the antiviral activity of INFτ was measured, as recently described [25] . Moreover, we tested the sensitivity of cultured pure endometrial epithelial cells to OT treatment. Only the non-pregnant bovine endometrium, at the late luteal and follicular phase of the cycle, is sensitive to OT treatment by PGF2α release [23] . Therefore, only the uteri that responded properly for the above tests were chosen for the respective pregnancy groups as described recently [5] . Based on the above, we excluded 3 uteri out of 7 in the AI group because of the lack of pregnancy.
The epithelial and stromal cells from the bovine endometrium were enzymatically separated (0.05% collagenase; Sigma Aldrich, St. Louis, MO, USA; # C0130) using procedures described previously [26] . Cell viability, measured by trypan blue staining, was higher than 85%. The two obtained pellets consisted of pure stromal cells and pure epithelial cells after the second passage [26] .
The homogeneity of the cells and contamination of the stromal and epithelial cell cultures (with epithelial cells and stromal cells, respectively) were evaluated using immunofluorescent staining for specific markers of epithelial (cytokeratin) and stromal cells (vimentin) [26] .
The final pellets of stromal and epithelial cells were resuspended in culture glass tubes (12 × 75 mm) containing 3 ml of culture medium (Dulbecco's Modified Eagle's Medium and Ham's F-12 medium 1:1 (v:v); Sigma; #D8900) supplemented with 0.1% BSA (Boehringer Mannheim GmbH, Mannheim, Germany; #735078), 100 IU/ml penicillin and 100 μg/ml streptomycin. The cells were incubated in glass tubes in a shaking water bath at 37 C as described previously for endometrial tissue explants [23] . The media were continuously gassed with 5% CO2 in air during incubation.
Isolated stromal and epithelial cells were resuspended in culture medium, in glass tubes as described above, preincubated for two hours (stabilization period) and then exposed to LPA (10 -6 M) for either 6 h (for the expression of mRNA transcripts for PGE2 synthase: PGES and PGF2α synthase PGFS in the cells) or 18 h (for PGE2 measurement in the culture medium). The dose of LPA was defined by preliminary experiments [5] . Tumor necrosis factor-α (TNFα Dainippon Pharmaceutical, Osaka, Japan; 6 × 10 -11 M) and OT (Sigma, #O4375; 10 -7 M) were used as positive controls for PG synthesis in stromal and epithelial cells, respectively [27] . After culture, the tubes were centrifuged (3500 rpm) in order to separate the cells from the conditioned media. The supernatants (conditioned media) were collected in tubes with 5 μl EDTA and 1% aspirin solution (pH 7.3; Sigma; #A2093) and frozen until measurement of PGF2α and PGE2 by enzyme immunoassay (EIA). The obtained pellet (treated cells) for real-time PCR was disrupted, frozen and stored at -80 C until RNA isolation. The DNA content was measured spectrophotometrically and was used to standardize PGF2α and PGE2 concentrations in the medium [27] . The PGF2α and PGE2 concentrations are expressed as ng/μg DNA. The expression of mRNA expression for the enzymes responsible for PGE2 and PGF2α synthesis (PGES and PGFS) was quantitatively measured by real-time PCR in the cell lysate. The results for the PGES mRNA expression in stromal and epithelial cells are expressed as arbitrary units normalized on the basis of the GAPDH mRNA content.
Hormone determination
The concentrations of P4, PGFM and PGE2 in the plasma and medium samples were determined with direct enzyme immunoassays (EIAs), as described previously [28] . The anti-P4 serum was donated by Prof S Okrasa, University of Warmia and Mazury in Olsztyn. The anti-PGFM serum (WS4468-5) was donated Dr WJ Silvia, University of Kentucky, Lexington, USA. The anti PGF2α and PGE2 sera were purchased from Sigma (#P5539 and #P5164, respectively). The P4 standard curve ranged from 0.39 pg/ml to 25 ng/ml, and the effective dose for 50% inhibition (ID50) of the assay was 2.85 ng/ml. The intra-and interassay coefficients of variation averaged 6.6 and 8.4%, respectively. The PGFM standard curve ranged from 32.5 to 8000 pg/ml, and the ID50 of the assay was 315 pg/ml. The intra-and interassay coefficients of variation were on average 7.6 and 10.4%, respectively. The PGE2 standard curve ranged from 0.07 to 20 ng/ml and the ID50 of the assay was 1.25 ng/ml. The intra-and inter-assay coefficients of variation were on average 6.9 and 9.7%, respectively. The PGF2α standard curve ranged from 0.016 to 4 ng/ml, and the ID50 of the assay was 0.25 ng/ml. The intra-and interassay coefficients of variation were on average 7.1 and 11.3%, respectively.
Total RNA extraction, reverse transcription (RT) and real-time PCR
Total RNA was extracted from stromal and epithelial cells using TRIzol (Invitrogen, Carlsbad, CA 92008, USA; #15596) according to the manufacturer's instructions. RNA samples were stored at -80 C. Before use, RNA was verified by spectrophotometric measurement and agarose gel electrophoresis. Two micrograms of each sample of total RNA was reverse transcribed using a ThermoScript TM RT-PCR System (Invitrogen; #11146-016). The RT reaction was performed in a total reaction volume of 20 μl, according to the manufacturer's instructions. RT products were stored at -20 C until real-time PCR amplification. The expression of mRNA for all examined genes was conducted by real time PCR using specific primers for PGES and PGFS as described previously [5, 6] . Briefly, GAPDH expression was used as an internal control. The primers were chosen using an online software package (http://frodo.wi.mit.edu/primer3/input.htm). The primers of all target genes are given in Table 1 .
Real-time PCR was performed with an ABI Prism 7300 sequence detection system using Power SYBR Green PCR master mix (Applied Biosystems, Foster City, CA 94404, USA; #4367659). The PCR reactions were performed in 96-well plates.
Each PCR reaction well (25 μl) contained 2.5 μl of diluted RT product, 200 pM of each forward and reverse primer, and 12.5 μl SYBR Green PCR master mix. As standard curves, serial dilutions of cDNA were used for mRNA expression. For the mRNA expres- sion levels, the primer length (20 bp) and GC contents of each primer (50-60%) were selected. Real-time PCR was performed under the following conditions: 95 C for 10 min, followed by 40 cycles of 94 C for 15 sec and 60 C for 60 sec. Each PCR reaction was followed by obtaining melting curves by increasing the temperature stepwise from 60 to 95 C to ensure single product amplification. In order to exclude the possibility of genomic DNA contamination in the RNA samples, the reactions were also run either on blank-only buffer samples or in the absence of reverse transcriptase. The specificity of the PCR products for all examined genes was confirmed by sequencing.
Statistical analysis
In Experiment 1, the differences in the plasma concentrations of P4, PGE2 and PGFM between the experimental groups and a control group at the specified time points were calculated using twoway ANOVA with the treatments and time of sample collection (hours) being fixed effects and all interactions included (GraphPad Prism Version 4.00; San Diego, CA, USA; P<0.05 was considered significant) [5] . The total amounts of released P4, PGE2 and PGFM were shown by the area under the curve (relative units; Tables 2 and 3 ) and were analyzed using one-way ANOVA followed by Bonferroni's Multiple Comparison Test (GraphPad Prism). In Experiment 2, all analyses were done using one-way ANOVA tests followed by the Dunnett Comparison Post Test, comparing all columns vs. the control column (GraphPad Prism; P<0.05 was considered significant).
Results
Experiment 1: The effect of LPA and VPC32183 on the pregnancy rate and secretion of P4 and PGs during early pregnancy
Preliminary study: Infusion of 0.5 mg of LPA elevated the concentrations of P4 in peripheral blood plasma at 0, 1, 2, 4, 10, 12, 18, 21 and 24 h after LPA infusion in comparison with the salineinfused heifers (Fig. 1a; P<0 .05). Infusion of 1 mg of LPA elevated the concentrations of P4 in peripheral blood plasma at 0.5, 1, 2, 3, 4, 6, 8, 14, 18 and 21 h after LPA infusion in comparison with the saline-infused heifers ( Fig. 1a; P<0 .05). Infusion of 10 mg of LPA elevated the concentrations of P4 in peripheral blood plasma at 4, 6, 10 and 14 h after LPA infusion in comparison with the salineinfused heifers (Fig. 1a; P<0 .05). Intravaginal infusion of 0.5, 1 and 10 mg of LPA elevated the total amount of secreted P4 in the blood plasma (Table 1 ; P<0.05). However, the highest increase of P4 concentration was noted after the infusion of 1 mg of LPA (Table 1; P<0.05; area under the curve).
Only intravaginal infusion of 1 mg of VPC32183 inhibited the stimulatory effect of 1 mg LPA on the P4 output ( Fig. 1b; P>0.05) . Infusion of 0.5 mg of VPC32183 elevated the concentrations of P4 in peripheral blood plasma at 1, 2, 4, 10, 12, 18, 21 and 24 h after LPA infusion in comparison with the saline infused heifers (Fig.  1b; P<0 .05). Infusion of 10 mg of VPC32183 elevated the concentrations of P4 in peripheral blood plasma at 0.5, 1, 2, 3, 4, 6, 8, 10, 12, 14, 16 and 21 h after LPA infusion in comparison with the saline infused heifers (Fig. 1b; P<0.05 ). Intravaginal infusion of 1 mg VPC32183 inhibited the LPA-induced increase in the total amount of secreted P4 in the blood plasma of heifers (Table 1; P>0.05; area under the curve).
Administration of 0.5 mg of LPA elevated the concentrations of PGE2 in peripheral blood at 1, 3 and 4 h after LPA infusion in comparison with the saline infused heifers (Fig. 2a, P<0 (Fig. 2a, P<0 .05). Administration of 10 mg of LPA elevated the concentrations of PGE2 in peripheral blood at 0, 3, 4 and 8 h after LPA infusion in comparison with the saline infused heifers (Fig.  2a, P<0.05 ). An increase in total secreted PGE2 was noted after infusion of 1 mg of LPA in comparison with the control heifers ( Table 1; 
P<0.05).
Intravaginal infusion of all selected doses of VPC32183 blocked the stimulatory effect of 1 mg LPA on the concentrations of PGE2 in peripheral blood during the 24 h after infusion (Fig. 2b, P>0 .05) and also inhibited the LPA-induced increase in the total amount of secreted PGE2 in the blood plasma of heifers (Table 1 ; P>0.05; area under the curve).
Intravaginal infusion of none of the selected doses of LPA had a detectable influence on the concentrations and total amount of PGFM in peripheral blood during the 24 h after LPA infusion (P>0.05; Table 1) .
Intravaginal pre-infusion of the selected doses of VPC32183 followed by 1 mg LPA had no detectable effect on the concentrations and total amount of PGFM in peripheral blood during the subsequent 24 h period (P>0.05; Table 1 ).
In the heifers infused with 1 mg LPA, spontaneous luteolysis was prevented, and the functional lifespan of the CL was prolonged in comparison with the animals of the control group. The length of the estrous cycle in the heifers treated with LPA was 28.2 ± 0.85 days, and that of the control group was 21.8 ± 0.65 days (Fig. 3,   P<0 .01). The length of the estrous cycle in the heifers treated with 1 mg VPC32183 (21.1 ± 1.1 days) did not differ from that of the group infused with saline (control group, 21.8 ± 0.65; P>0.05).
Based on the results of the preliminary study, 1 mg LPA and 1 mg VPC32183 were found to be the most effective doses, and thus, they were chosen for the main experiment. Administration of 1 mg of LPA increased the P4 and PGE2 concentrations for at least 24 h after application (Figs. 1 and 2) . Moreover, infusion of 1 mg of VPC32183 blocked the stimulatory effect of 1 mg LPA on the concentrations of P4 in the peripheral blood for at least 24 h after infusion. Therefore, in the next part of the study, we decided to treat animals with these two substances (LPA and VPC32183) once daily, between days 15 and 18 after insemination.
The effect of LPA and VPC32183 on the pregnancy rate and the secretion of P4 and PGs during early pregnancy: The concentrations of P4 in the blood of the heifers infused with 1 mg LPA were significantly higher throughout the experimental period than those of the saline-and VPC32183-infused heifers ( Fig. 4; Table 3 ; P<0.05; area under the curve). For the P4 concentrations, threeway interactions were found between LPA treatment, saline treatment and time of sample collection (P<0.01; Fig. 4) . Moreover, for the P4 concentration, we found three-way interactions between VPC32183 treatment, saline treatment and time of sample collection (P<0.05 Fig. 4 ) and between LPA treatment, VPC31283 treatment and time of sample collection (P<0.01; Fig. 4) . Asterisks (*P<0.05) indicate significant differences at the specified time points in the mean ± SEM plasma concentrations of P4 between the control and experimental heifers (n=3 for each group of heifers). All reagents were infused into the vagina. Different subscript letters indicate significant differences (P<0.05) between treated groups. Asterisks (* P<0.05) indicate significant differences at the specified time points in the mean ± SEM plasma concentrations of P4 between the control and experimental heifers (n=3 for each group of heifers).
The concentrations of PGE2 in the blood of the heifers infused with 1 mg LPA throughout the experimental period were significantly higher than those in the saline-and VPC32183-infused pregnant heifers ( Fig. 5; Table 3 ; P<0.05). For the PGE2 concentrations, three-way interactions were found between LPA treatment, saline treatment and time of sample collection (P<0.05; Fig. 5 ) and between LPA treatment, VPC31283 treatment and time of sample collection (P<0.05; Fig. 5 ).
The concentrations of PGFM in the blood of the all heifers from all experimental groups did not differ throughout the experimental period (P>0.05; data not shown).
In the saline-and LPA-treated groups, 6 out of 8 heifers were pregnant (75%; in each group; P>0.05), whereas the pregnancy rate in the VPC32183-treated heifers was about 37% (3 out of 8 heifers were pregnant; P<0.05). The pregnancy was confirmed by ultrasonography (USG) and per rectum examination on days 30 and 49-50 after insemination.
Experiment 2: The effect of LPA on PG secretion and PGES and PGFS mRNA expression in stromal and epithelial cells of the bovine endometrium on Days 16-18 of the estrous cycle and pregnancy
The effect of LPA on PGE2 production in bovine endometrial cells: TNFα and OT stimulated production of PGE2 in stromal and epithelial cells on days 16-18 of the estrous cycle, respectively ( Fig. 6; P<0 .05), which accounts for appropriate responsiveness of the cells. Although LPA stimulated PGE2 secretion in stromal cells on days 16-18 of the estrous cycle compared with the controls (Fig.  6 ; P<0.05), the strongest effect on PGE2 secretion in stromal cells was noted on days 16-18 of pregnancy compared with the controls (Fig. 6; P<0 .01). On days 16-18 of the estrous cycle and pregnancy, LPA did not influence PGE2 secretion in the epithelial cells compared with the controls (Fig. 6; P>0.05) .
The effect of LPA on PGF2α production in bovine endometrial cells: TNFα and OT stimulated production of PGF2α in stromal and epithelial cells on days 16-18 of the estrous cycle, respectively ( Fig. 7; P<0 .01), which accounts for appropriate responsiveness of the cells. LPA did not influence PGF2α secretion in stromal and epithelial cells on days 16-18 of the estrous cycle and in stromal cells on days 16-18 of pregnancy ( Fig. 7; P>0 .05). On days 16-18 of pregnancy, LPA inhibited PGF2α secretion in epithelial cells compared with the controls (Fig. 7; P<0 .05). M) and OT (10 -7 M) were added 18 h before the end of culture. Asterisks, *(P<0.05) and **(P<0.01), indicate statistical differences between the control and treated groups (n=6 for the estrous cycle group, n=4 for the pregnancy group). The effect of LPA on PGES mRNA expression in bovine endometrial cells: LPA stimulated PGES mRNA expression in stromal cells on days 16-18 of both the estrous cycle and pregnancy ( Fig. 8a, b (Fig. 8d ; P<0.05).
Discussion
We have previously demonstrated that LPA, which is a simple phospholipid with a variety of physiological and pathological actions [29] [30] [31] [32] [33] , administered into the aorta abdominalis affected P4 and PG secretion during the luteal phase of the estrous cycle in the cow [5] . In the present study, we examined the potential influence of LPA on early pregnancy in the cow. Therefore, we had to choose the effective dose of LPA and VPC32183 administered by a less invasive route (intravaginally) on the secretion of P4 and PGs during the luteal phase of the estrous cycle. We changed the route of administration of the examined substances from the aorta abdominalis to vagina in order to avoid additional surgical stress while studying the influence of LPA on the establishment of early pregnancy in the cow. The obtained data demonstrate that the chosen way of LPA administration is as effective as LPA administration directly into blood vessels in the area of reproductive organs and thus may be potentially applied for LPA-mediated regulation of the estrous cycle in the cow.
In Experiment 1, we demonstrated that LPA had a strong effect on P4 and PGE2 secretion during early pregnancy. These data suggest that LPA takes part in early pregnancy establishment in the cow through its influences on both the endometrium and the CL. Moreover, we proved that blocking the effect of endogenous LPA by administration of VPC32183 significantly decreased the pregnancy rate compared with the control and LPA-treated heifers. The lack of the inhibitory effects of LPA on the PGFM concentrations in the peripheral blood does not agree with our previous results obtained in vitro [6] . However, in the present study under in vivo conditions, the lack of the inhibitory effects of LPA on the PGFM concentrations in the peripheral blood may be due to the fact that the blood concentration of PGFM may not strictly reflect the local (uterine) PGF2α production during early pregnancy. During early pregnancy establishment, PGF2α concentration in the ovarian vein and the peripheral PGF2α concentration (in the jugular vein) are decreasing due to the countercurrent exchange between the uterine venous drainage and the ovarian artery [36] [37] [38] . It was documented a long ago that PGF2α is transferred back from the mesometrial vasculature into the uterus, which reduces the amplitude of PGF2α pulses in the uterine venous blood and decreases the penetration of PGF2α into the subovarian area and from there to the CL [36] [37] [38] . Therefore, in our study, the local effect of LPA on PGF2α secretion measured in the jugular vein could not be determined. Thus, the next aim of the study was to examine the local effect of LPA on the synthesis of PGs in the bovine endometrium in vitro in order to confirm the obtained in vivo effect.
In Experiment 2, we studied the influence of LPA on PG synthesis and secretion in bovine stromal and epithelial endometrial cells in vitro at the time of early pregnancy establishment compared with the respective days of the estrous cycle. We also examined which enzymes are responsible for this action within the bovine uterus. The results obtained in vitro confirmed the data from the experiment in vivo showing that LPA stimulated PGE2 synthesis via stimulation of PGES mRNA expression in stromal cells on days 16-18 of the estrous cycle and pregnancy. Moreover, LPA inhibited PGF2α synthesis via stimulation of PGFS mRNA expression in epithelial cells on days 16-18 of pregnancy. These data are consistent with the data from our previous study [6] . We had previously shown that LPA stimulated PGE2 synthesis in stromal cells on days 8-10 of estrous cycle and pregnancy and also inhibited PGF2α synthesis in epithelial cells on days 8-10 of pregnancy [6] . Although we did not examine either the LPA receptors, intracellular signaling pathways or transcription factors involved in LPA-mediated PGE2 and PGF2α stimulation in the present study, we hypothesize that these molecular mechanisms might be similar to the LPAinduced PTGS2 expression demonstrated by Oyesanya et al. [39] . They have recently shown that LPA-induced expression of PTGS2 involves both transcriptional and post-transcriptional regulation in ovarian cancer cells [39] . The transcriptional activation of PTGS2 by LPA is mediated primarily by the CCAAT enhancer-binding protein (C/EBP) transcription factor independently of other transcription factors commonly involved in inducible PTGS2 expression. C/EBP is activated by LPA via a regulatory mechanism integrating LPA-LPARs signals and a permissive activity from a receptor tyrosine kinase (RTK) [39] . It has also been demonstrated that the transcriptional stimulation is reinforced by posttranscriptional protection of PTGS2 mRNA stability mediated by the RNA binding protein HuR [40] , leading to sustained induction of PTGS2 in LPA-treated cells [39] . However, thorough investigation is needed to clarify the molecular mechanisms of LPA influenced PGES and PGFS expression in bovine endometrial cells.
The overall results suggest that LPA is a luteoprotective factor in the bovine endometrium during both the estrous cycle and early pregnancy establishment. It stimulates P4 and PGE2 secretion in vivo. Since PGE2 stimulates CL function [41, 42] and has roles in establishing and maintaining pregnancy [18, 43] , LPA-mediated stimulation of PGE2 synthesis and additional inhibition of PGF2α synthesis may be an important factor contributing to the establishment of pregnancy in the bovine endometrium. The obtained data seem to be important because the examined time frame (days 15-18) represent a critical period in the establishment of pregnancy. This is the time of the highest IFNτ production by the conceptus, just before implantation therefore, the interactions between LPA and IFNτ cannot be excluded.
In conclusion, the present study demonstrates that LPA may serve as a luteotropic factor during the establishment of early pregnancy, stimulating P4 and PGE2 secretion. On days 16-18 of the estrous cycle and pregnancy, LPA increased PGE2 synthesis through activation of PGES expression in stromal cells. Moreover, during early pregnancy, LPA decreased PGF2α synthesis and mRNA expression for PGFS in epithelial cells of the bovine endometrium.
